Pediatric Department, Faculty of Medicine, Ain Shams University, Abbasia, Cairo, Egypt.
Complement Ther Clin Pract. 2013 Feb;19(1):15-9. doi: 10.1016/j.ctcp.2012.08.002. Epub 2012 Oct 9.
This study was a case control cross sectional study that was conducted on 50 patients with type 1 diabetes mellitus and 30 controls without diabetes. The mean age of patients was 10.02 years. Oral sugar tolerance tests using glucose, sucrose and honey and measurement of fasting and postprandial serum C-peptide levels were done for all subjects in three separate sittings. The glycemic index (GI) and the peak incremental index (PII) were then calculated for each subject. Honey, compared to sucrose, had lower GI and PII in both patients and controls (P < 0.01). In both patients and controls, the increase in the level of C-peptide after honey was significant when compared with either glucose or sucrose (P < 0.01).
Because of its possible stimulatory effect on diseased beta cells, honey might be considered in future therapeutic trials targeting beta cells of pancreas.
本研究为病例对照的横断面研究,共纳入 50 例 1 型糖尿病患者和 30 例无糖尿病对照者。患者平均年龄为 10.02 岁。所有受试者分 3 次进行口服糖耐量试验(葡萄糖、蔗糖和蜂蜜)和空腹及餐后血清 C 肽水平检测。然后计算每位受试者的血糖指数(GI)和峰值增量指数(PII)。蜂蜜的 GI 和 PII 低于蔗糖,在患者和对照者中均如此(P<0.01)。与葡萄糖或蔗糖相比,患者和对照者在摄入蜂蜜后 C 肽水平的升高均有显著差异(P<0.01)。
由于蜂蜜对病变的β细胞可能具有刺激作用,因此在针对胰腺β细胞的未来治疗试验中可以考虑使用蜂蜜。